Dr. Mark R. Bortolus obtained his Honors B.Sc. and Ph.D. Chemistry degrees at McMaster University under the supervision of Professor Gary J. Schrobilgen in the fields of synthetic inorganic fluorine chemistry and noble-gas chemistry. A prominent theme of Mark’s Ph.D. Thesis research was the application of noble-gas (krypton and xenon) compounds to the syntheses of novel fluoro- and oxyfluoro-derivatives of main-group and transition-metal elements in their highest oxidation states.  During his graduate work, Mark received several competitive graduate awards such as the McMaster Health and Safety Award of Excellence (awarded for the first time to a graduate student), the Prof. Ronald J. Gillespie Prize in Inorganic Chemistry, and the Alexander Graham Bell Doctoral NSERCC (National Science & Engineering Research Council of Canada) Scholarship. The publications that resulted from Mark’s Ph.D. Dissertation are published in high-impact journals and are internationally recognized as significant contributions to the fields of inorganic fluorine chemistry, high-oxidation state transition-metal chemistry, and noble-gas chemistry.  Dr. Bortolus is currently an NSERC Postdoctoral Research Fellow at the University of Toronto where he works with Prof. Neil Vasdev, Director and Chief Radiochemist, at the Centre for Addiction and Mental Health, and is applying his expertise in synthetic inorganic fluorine chemistry to the development of new 18F radiofluorination methodologies for the syntheses of radiotracers that are useful for in vivo imaging of the human brain by means of Positron Emission Tomography.

Dr. Mark R. Bortolus obtained his Honors B.Sc. and Ph.D. Chemistry degrees at McMaster University under the supervision of Professor Gary J. Schrobilgen in the fields of synthetic inorganic fluorine chemistry and noble-gas chemistry. A prominent theme of Mark’s Ph.D. Thesis research was the application of noble-gas (krypton and xenon) compounds to the syntheses of novel fluoro- and oxyfluoro-derivatives of main-group and transition-metal elements in their highest oxidation states.  During his graduate work, Mark received several competitive graduate awards such as the McMaster Health and Safety Award of Excellence (awarded for the first time to a graduate student), the Prof. Ronald J. Gillespie Prize in Inorganic Chemistry, and the Alexander Graham Bell Doctoral NSERCC (National Science & Engineering Research Council of Canada) Scholarship. The publications that resulted from Mark’s Ph.D. Dissertation are published in high-impact journals and are internationally recognized as significant contributions to the fields of inorganic fluorine chemistry, high-oxidation state transition-metal chemistry, and noble-gas chemistry.  Dr. Bortolus is currently an NSERC Postdoctoral Research Fellow at the University of Toronto where he works with Prof. Neil Vasdev, Director and Chief Radiochemist, at the Centre for Addiction and Mental Health, and is applying his expertise in synthetic inorganic fluorine chemistry to the development of new 18F radiofluorination methodologies for the syntheses of radiotracers that are useful for in vivo imaging of the human brain by means of Positron Emission Tomography.

Prof. Neil Vasdev is the Director and Chief Radiochemist of the Centre for Addiction and Mental Health (CAMH) Brain Health Imaging Centre, and the Director of the Azrieli Centre for Neuro-Radiochemistry at CAMH. He is also the endowed Azrieli Chair in Brain and Behaviour, and a Tier 1 Canada Research Chair in Radiochemistry and Medical Imaging. In addition, he is a full Professor in the Department of Psychiatry at the University of Toronto. Neil started his radiochemistry and neuroimaging training while obtaining his Bachelor degrees (summa cum laude) in Chemistry and Psychology followed by a PhD supported by NSERC at McMaster University. He continued training with a NSERC postdoctoral fellowship in the Department of Nuclear Medicine and Functional Imaging at the E.O. Lawrence Berkeley National Laboratory in California. He began his independent faculty career in radiopharmaceutical sciences at CAMH/University of Toronto in 2004. In 2011 he joined the leadership of the Department of Nuclear Medicine and Molecular Imaging at the Massachusetts General Hospital and Harvard Medical School. From 2011-2017 he served as the Director of Radiochemistry and Associate Centre Director at the Massachusetts General Hospital and joined the faculty of Medicine as an Associate Professor in the Department of Radiology at Harvard Medical School. He was recruited back to CAMH and the University of Toronto in 2018. He has published nearly 200 peer-reviewed articles, delivered over 100 lectures worldwide He is a Fellow of the American Chemical Society, Royal Society of Chemistry, and the SNMMI. Neil is a co-founder of MedChem Imaging, Inc., a Boston-based contract research organization (CRO), and has over 10 families of patents, several of which have been licensed to the pharmaceutical industry.
Prof. Neil Vasdev is the Director and Chief Radiochemist of the Centre for Addiction and Mental Health (CAMH) Brain Health Imaging Centre, and the Director of the Azrieli Centre for Neuro-Radiochemistry at CAMH. He is also the endowed Azrieli Chair in Brain and Behaviour, and a Tier 1 Canada Research Chair in Radiochemistry and Medical Imaging. In addition, he is a full Professor in the Department of Psychiatry at the University of Toronto. Neil started his radiochemistry and neuroimaging training while obtaining his Bachelor degrees (summa cum laude) in Chemistry and Psychology followed by a PhD supported by NSERC at McMaster University. He continued training with a NSERC postdoctoral fellowship in the Department of Nuclear Medicine and Functional Imaging at the E.O. Lawrence Berkeley National Laboratory in California. He began his independent faculty career in radiopharmaceutical sciences at CAMH/University of Toronto in 2004. In 2011 he joined the leadership of the Department of Nuclear Medicine and Molecular Imaging at the Massachusetts General Hospital and Harvard Medical School. From 2011-2017 he served as the Director of Radiochemistry and Associate Centre Director at the Massachusetts General Hospital and joined the faculty of Medicine as an Associate Professor in the Department of Radiology at Harvard Medical School. He was recruited back to CAMH and the University of Toronto in 2018. He has published nearly 200 peer-reviewed articles, delivered over 100 lectures worldwide He is a Fellow of the American Chemical Society, Royal Society of Chemistry, and the SNMMI. Neil is a co-founder of MedChem Imaging, Inc., a Boston-based contract research organization (CRO), and has over 10 families of patents, several of which have been licensed to the pharmaceutical industry.

Lee Collier has a diverse background in the scientific field, with a range of experience in various roles and organizations. Lee began their career in 1989 as a Post Doc at Paracel Laboratories Ltd. and later at the University of Tennessee. Lee then worked as a Senior Scientist at the Australian Nuclear Science and Technology Organization from 1993 to 1996. Collier then joined Columbia University Medical Center as an Assistant Professor, focusing on PET tracers for use in Cardiology and teaching classes on radiotracers for diagnostic imaging.

In 2003, Collier moved to Siemens Medical Solutions, where they served as a Senior Staff Scientist until 2008. Lee joined Advion Interchim Scientific in 2009 and held roles as both a Senior Scientist in Radiochemistry and as the Manager of Customer Service for North America. During this time, they also held visiting scientist positions at the University of Tennessee Graduate School of Medicine, Massachusetts General Hospital, and Harvard Medical School.

Currently, Collier is a Visiting Scientist at Emory University, where they continue to contribute their expertise in the field. Lee Collier completed a Bachelor of Science (BSc) degree in science at Carleton University from 1978 to 1982. Later, from 1982 to 1990, Lee pursued further education at Carleton University and earned a Doctor of Philosophy (Ph.D.) in Chemistry.

Lee Collier has a diverse background in the scientific field, with a range of experience in various roles and organizations. Lee began their career in 1989 as a Post Doc at Paracel Laboratories Ltd. and later at the University of Tennessee. Lee then worked as a Senior Scientist at the Australian Nuclear Science and Technology Organization from 1993 to 1996. Collier then joined Columbia University Medical Center as an Assistant Professor, focusing on PET tracers for use in Cardiology and teaching classes on radiotracers for diagnostic imaging.

In 2003, Collier moved to Siemens Medical Solutions, where they served as a Senior Staff Scientist until 2008. Lee joined Advion Interchim Scientific in 2009 and held roles as both a Senior Scientist in Radiochemistry and as the Manager of Customer Service for North America. During this time, they also held visiting scientist positions at the University of Tennessee Graduate School of Medicine, Massachusetts General Hospital, and Harvard Medical School.

Currently, Collier is a Visiting Scientist at Emory University, where they continue to contribute their expertise in the field. Lee Collier completed a Bachelor of Science (BSc) degree in science at Carleton University from 1978 to 1982. Later, from 1982 to 1990, Lee pursued further education at Carleton University and earned a Doctor of Philosophy (Ph.D.) in Chemistry.

For every modern coworking or office space website out there.

Contact info

Koralgatan 1, 215
70 Malmö, Sweden

+3842 1773 59 11

qi147@example.com